15 years ago

nanoTherics Secures £1.1 Million to Advance Nanoparticle-Based Cancer Therapies

  • nanoTherics, a UK-based company developing nanoparticle-based cancer therapies, has secured £1.1 million in funding

  • The funding will be used to advance the company's lead product candidate, which targets a specific type of cancer

  • The company is aiming to improve treatment efficacy and reduce side effects with its novel approach.

      • Covered on